Cytomegalovirus Seropositivity Is Associated with Increased Arterial Stiffness in Patients with Chronic Kidney Disease

Background Patients with chronic kidney disease have an increased cardiovascular risk that is not fully explained by traditional risk factors but appears to be related to increased arterial stiffness. Cytomegalovirus (CMV) infection is associated with increased cardiovascular risk although the mechanisms for this are unknown. We examined whether CMV seropositivity was associated with increased arterial stiffness in patients with chronic kidney disease. Methodology and Principal Findings In 215 non-diabetic patients with chronic kidney disease, CMV seropositivity was determined using an anti-CMV IgG ELISA. Pulse wave velocity was measured and aortic distensibility assessed in the ascending, proximal descending and distal descending thoracic aorta. Patients seropositive for CMV had a higher pulse wave velocity and lower aortic distensibility at all 3 levels. These differences (except for ascending aortic distensibility) persisted in a subcohort matched for age, gender and renal function, and when the whole cohort was divided into quartiles of age. In multivariable analyses, CMV seropositivity was an independent determinant of pulse wave velocity and proximal and distal descending aortic distensibility. Conclusions In patients with chronic kidney disease, CMV seropositivity is associated with increased arterial stiffness and decreased distensibility of the proximal descending and distal aorta. These findings suggest that further research is required to examine CMV as a possible cause of arterial disease and increased cardiovascular risk in patients with CKD and may be relevant more widely for CMV seropositive patients with normal renal function.

[1]  A. Sharrett,et al.  Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. , 2012, The Journal of infectious diseases.

[2]  T. Lehtimäki,et al.  Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow‐mediated dilation in young men: the Cardiovascular Risk in Young Finns Study , 2012, Clinical and experimental immunology.

[3]  Xueqing Yu,et al.  Signature microRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection , 2011, Circulation.

[4]  P. Caposio,et al.  The role of cytomegalovirus in angiogenesis. , 2011, Virus Research.

[5]  F. Baas,et al.  Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. , 2010, The Journal of clinical investigation.

[6]  M. Cannon,et al.  Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection , 2010, Reviews in medical virology.

[7]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.

[8]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[9]  J. Townend,et al.  Arterial stiffness in chronic kidney disease: causes and consequences , 2010, Heart.

[10]  P. Sedgwick Matching , 2009, BMJ : British Medical Journal.

[11]  J. Townend,et al.  Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. , 2009, Journal of the American College of Cardiology.

[12]  C. Crumpacker,et al.  Cytomegalovirus Infection Causes an Increase of Arterial Blood Pressure , 2009, PLoS pathogens.

[13]  G. Dolivet,et al.  Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  De⁃xin Wang,et al.  Detection of human cytomegalovirus in atherosclerotic carotid arteries in humans. , 2008, Journal of the Formosan Medical Association = Taiwan yi zhi.

[15]  V. Bellizzi,et al.  [Prevalence of chronic kidney disease]. , 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

[16]  A. Steptoe,et al.  Socioeconomic status and cardiovascular disease risk - The authors' reply , 2008 .

[17]  A. Steptoe,et al.  The authors' reply: , 2008, Heart.

[18]  J. Mieczkowska,et al.  Socioeconomic status and cardiovascular disease risk , 2008, Heart.

[19]  J. Deanfield,et al.  Endothelial Dysfunction and Cytomegalovirus Replication in Pediatric Heart Transplantation , 2008, Circulation.

[20]  J. Connell,et al.  Aortic Stiffness and Diastolic Flow Abnormalities in End-Stage Renal Disease Assessed by Magnetic Resonance Imaging , 2008, Nephron Clinical Practice.

[21]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[22]  M. Majesky Developmental basis of vascular smooth muscle diversity. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[23]  B. Henderson,et al.  Socioeconomic status, pathogen burden and cardiovascular disease risk , 2006, Heart.

[24]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[25]  J. Townend,et al.  The treatment of coronary artery disease in patients with chronic kidney disease. , 2006, QJM : monthly journal of the Association of Physicians.

[26]  B. Narasimhan,et al.  Acute Rejection and Cardiac Allograft Vascular Disease Is Reduced by Suppression of Subclinical Cytomegalovirus Infection , 2006, Transplantation.

[27]  M. Yoshizumi,et al.  Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. , 2005, Journal of the American College of Cardiology.

[28]  G. Ridgway,et al.  Human Cytomegalovirus Seropositivity Is Associated With Impaired Vascular Function , 2003, Circulation.

[29]  J. Brophy,et al.  Absence of Association Between Infectious Agents and Endothelial Function in Healthy Young Men , 2003, Circulation.

[30]  S. Yusuf,et al.  Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study , 2003, Circulation.

[31]  D. Levy,et al.  The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. , 2002, Journal of the American College of Cardiology.

[32]  S. Blankenberg,et al.  Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection? , 2000, Stroke.

[33]  A. Folsom,et al.  A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. , 2000, Archives of internal medicine.

[34]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[35]  A de Roos,et al.  Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. , 1998, The American journal of cardiology.

[36]  H. Miller,et al.  High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. , 1998, The American journal of cardiology.

[37]  M. Daemen,et al.  Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: a study in rat. , 1997, Cardiovascular research.

[38]  P. Sorlie,et al.  Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. , 1996, Circulation.

[39]  D G Altman,et al.  Statistics notes: Matching , 1994 .

[40]  T. Merigan,et al.  A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. , 1992, The New England journal of medicine.

[41]  C. Bruggeman,et al.  Infection and atherosclerosis. An alternative view on an outdated hypothesis. , 2008, Pharmacological reports : PR.

[42]  J. Lin,et al.  Detection of human cytomegalovirus in the atherosclerotic cerebral arteries in Han population in China. , 2008, Acta virologica.

[43]  M. Yoshizumi,et al.  Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. , 2005, Journal of the American College of Cardiology.

[44]  G. Vetrovec,et al.  Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. , 1998, The Journal of infectious diseases.